SCHEMBL4690065

SCHEMBL4690065

Nc1ncnc2cc(OCCN3CCOCC3)ccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54
ILK Q13418 1/20 0.52
SRC P12931 2/20 0.52
FGFR1 P11362 1/20 0.52
NPC1 O15118 2/20 0.51
MAOA P21397 2/20 0.50
BCHE P06276 1/20 0.50
ACHE P22303 1/20 0.50
MAOB P27338 1/20 0.50
GRM4 Q14833 1/20 0.50
MET P08581 2/20 0.49
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
CHEK1 O14757 1/20 0.49
KDR P35968 1/20 0.48
MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4429202 0.94 SRC (0.55) ALDH1A1SRCFGFR1GRM4CHEK1
SCHEMBL30783040 0.94 SRC (0.55) ALDH1A1SRCFGFR1GRM4CHEK1
SCHEMBL4416516 0.89 MAP4K4 (0.57) KDM4EGRM4LTA4HMAP4K4
SCHEMBL31298956 0.89 MAP4K4 (0.57) KDM4EGRM4LTA4HMAP4K4
SCHEMBL4424443 0.88 MAP4K4 (0.56) MAOBGRM4LTA4HMAP4K4
SCHEMBL4431344 0.86 SIGMAR1 (0.50) KDM4EALDH1A1MEN1KMT2ALTA4H
SCHEMBL4507750 0.85 KDM4E (0.61) KDM4EALDH1A1ILKSRCFGFR1
SCHEMBL13841371 0.85 NPC1 (0.57) KDM4EALDH1A1ILKSRCFGFR1
SCHEMBL239668 0.84 SIGMAR1 (0.56) ALDH1A1SRCFGFR1ACHECHEK1
SCHEMBL15483915 0.83 ILK (0.55) KDM4EALDH1A1ILKSRCFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed